848
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Assessment of Corneal Epithelial Changes and Related Factors in Ocular Chronic Graft-Versus-Host Disease (GVHD) by in Vivo Confocal Microscopy

, MBORCID Icon, , MDORCID Icon, , MD, , MM, , MB, , MB & , MDORCID Icon show all
Pages 454-462 | Received 14 Feb 2022, Accepted 22 Jan 2023, Published online: 09 Feb 2023

References

  • Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2003;9(4):215–233. doi:10.1053/bbmt.2003.50026.
  • Jagasia MH, Greinix HT, Arora M, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21(3):389–401.e1. doi:10.1016/j.bbmt.2014.12.001.
  • Ferrara JL, Levine JE, Reddy P, et al. Graft-versus-host disease. Lancet. 2009;373(9674):1550–1561. doi:10.1016/S0140-6736(09)60237-3.
  • Franklin RM, Kenyon KR, Tutschka PJ, et al. Ocular manifestations of graft-vs-host disease. Ophthalmology. 1983;90(1):4–13. doi:10.1016/S0161-6420(83)34604-2.
  • Shikari H, Antin JH, Dana R. Ocular graft-versus-host disease: a review. Surv Ophthalmol. 2013;58(3):233–251. doi:10.1016/j.survophthal.2012.08.004.
  • Hessen M, Akpek EK. Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol. 2012;12(5):540–547. doi:10.1097/ACI.0b013e328357b4b9.
  • Townley JR, Dana R, Jacobs DS. Keratoconjunctivitis sicca manifestations in ocular graft versus host disease: pathogenesis, presentation, prevention, and treatment. Semin Ophthalmol. 2011;26(4–5):251–260. doi:10.3109/08820538.2011.588663.
  • Claes K, Kestelyn P. Ocular manifestations of graft versus host disease following bone marrow transplantation. Bull Soc Belge Ophtalmol. 2000;(277):21–26.
  • Anderson NG, Regillo C. Ocular manifestations of graft versus host disease. Curr Opin Ophthalmol. 2004;15(6):503–507. doi:10.1097/01.icu.0000143684.22362.46.
  • Yeh PT, Hou Y-C, Lin W-C, et al. Recurrent corneal perforation and acute calcareous corneal degeneration in chronic graft-versus-host disease. JFormos Med Assoc. 2006;105(4):334–339. doi:10.1016/S0929-6646(09)60125-X.
  • Hu B, Qiu Y, Hong J. Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD). Ocul Surf. 2020;18(2):298–304. doi:10.1016/j.jtos.2019.12.005.
  • Nair S, Vanathi M, Mahapatra M, et al. Tear inflammatory mediators and protein in eyes of post allogenic hematopoeitic stem cell transplant patients. Ocul Surf. 2018;16(3):352–367. doi:10.1016/j.jtos.2018.04.007.
  • Cocho L, Fernández I, Calonge M, et al. Biomarkers in ocular chronic graft versus host disease: tear cytokine- and chemokine-based predictive model. Invest Ophthalmol Vis Sci. 2016;57(2):746–758. doi:10.1167/iovs.15-18615.
  • Sinha S, Singh RB, Dohlman TH, et al. Prevalence of persistent corneal epithelial defects in chronic ocular graft-versus-host disease. Am J Ophthalmol. 2020;218:296–303. doi:10.1016/j.ajo.2020.05.035.
  • Tepelus TC, Chiu GB, Maram J, et al. Corneal features in ocular graft-versus-host disease by in vivo confocal microscopy. Graefes Arch Clin Exp Ophthalmol. 2017;255(12):2389–2397. doi:10.1007/s00417-017-3759-x.
  • Pérez R, Pérez-Simón JA, Caballero-Velazquez T, et al. Limbus damage in ocular graft-versus-host disease. Biol Blood and Marrow Transplant. 2011;17(2):270–273.
  • Ogawa Y, Kim SK, Dana R, et al. International chronic ocular Graft-vs-Host-Disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep. 2013;3:3419. doi:10.1038/srep03419.
  • Kellar KL, Iannone MA. Multiplexed microsphere-based flow cytometric assays. Exp Hematol. 2002;30(11):1227–1237. doi:10.1016/S0301-472X(02)00922-0.
  • Huang XJ, Liu D-H, Liu K-Y, et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant. 2006;38(4):291–297. doi:10.1038/sj.bmt.1705445.
  • Pauly A, Labbe A, Baudouin C, et al. In vivo confocal microscopic grading system for standardized corneal evaluation: application to toxic-induced damage in rat. Current Eye Research. 2008;33(10):826–838. doi:10.1080/02713680802381460.
  • Pauly A, Brignole-Baudouin F, Labbe´ A, et al. New tools for the evaluation of toxic ocular surface changes in the rat. Invest Ophthalmol Vis Sci. 2007;48(12):5473–5483. doi:10.1167/iovs.06-0728.
  • Kheirkhah A, Qazi Y, Arnoldner MA, et al. In vivo confocal microscopy in dry eye disease associated with chronic graft-versus-host disease. Invest Ophthalmol Vis Sci. 2016;57(11):4686–4691. doi:10.1167/iovs.16-20013.
  • He J, Ogawa Y, Mukai S, et al. In vivo confocal microscopy evaluation of ocular surface with graft-versus-host disease-related dry eye disease. Sci Rep. 2017;7(1):10720. doi:10.1038/s41598-017-10237-w.
  • Villani E, Mantelli F, Nucci P. In-vivo confocal microscopy of the ocular surface: ocular allergy and dry eye. Curr Opin Allergy Clin Immunol. 2013;13(5):569–576. doi:10.1097/ACI.0b013e328364ec92.
  • Guthoff R, Zhivov A, Stachs O, et al. In vivo confocal microscopy, an inner vision of the cornea - a major review. Clin Exp Ophthalmol. 2009;37(1):100–117. doi:10.1111/j.1442-9071.2009.02016.x.
  • Zhang X, Chen Q, Chen W, et al. Tear dynamics and corneal confocal microscopy of subjects with mild self-reported office dry eye. Ophthalmology. 2011;118(5):902–907. doi:10.1016/j.ophtha.2010.08.033.
  • Steger B, Speicher L, Philipp W, et al. In vivo confocal microscopic characterisation of the cornea in chronic graft-versus-host disease related severe dry eye disease. Br J Ophthalmol. 2015;99(2):160–165. doi:10.1136/bjophthalmol-2014-305072.
  • Jung JW, Han SJ, Song MK, et al. Tear cytokines as biomarkers for chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21(12):2079–2085. doi:10.1016/j.bbmt.2015.08.020.
  • Brazzell RK, Stern ME, Aquavella JV, et al. Human recombinant epidermal growth factor in experimental corneal wound healing. Invest Ophthalmol Vis Sci. 1991;32(2):336–340.
  • Gordon GM, Austin JS, Sklar AL, et al. Comprehensive gene expression profiling and functional analysis of matrix metalloproteinases and timps, and identification of ADAM-10 gene expression, in a corneal model of epithelial resurfacing. J Cell Physiol. 2011;226(6):1461–1470. doi:10.1002/jcp.22306.
  • Schneider P, MacKay F, Steiner V, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med. 1999;189(11):1747–1756. doi:10.1084/jem.189.11.1747.
  • Kimberley FC, Medema JP, Hahne M. April in B-cell malignancies and autoimmunity. Results Probl Cell Differ. 2009;49:161–182.
  • Wilson SE, Lloyd SA, He YG. EGF, basic FGF, and TGF beta-1 messenger RNA production in rabbit corneal epithelial cells. Invest Ophthalmol Vis Sci. 1992;33:1987–1995.
  • Wilson SE, He YG, Lloyd SA. EGF, EGF receptor, basic FGF, TGF beta-1, and IL-1 alpha mRNA in human corneal epithelial cells and stromal fibroblasts. Invest Ophthalmol Vis Sci. 1992;33:1756–1765.
  • Carreno-Galeano JT, Dohlman TH, Kim S, Yin J, Dana, R. A review of ocular graft-versus-host disease: pathophysiology, clinical presentation and management. Ocul Immunol Inflamm. 2021;29:1–10.
  • Gospodarowicz D, Mescher AL, Brown KD, et al. The role of fibroblast growth factor and epidermal growth factor in the proliferative response of the corneal and lens epithelium. Exp Eye Res. 1977;25(6):631–649. doi:10.1016/0014-4835(77)90142-7.
  • Petroutsos G, Courty J, Guimaraes R, et al. Comparison of the effects of EGF, pFGF and EDGF on corneal epithelium wound healing. Curr Eye Res. 1984;3(4):593–598. doi:10.3109/02713688409003059.
  • Wilson SE, He Y-G, Weng J, et al. Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor, on proliferation, motility and differentiation of human corneal epithelial cells. Exp Eye Res. 1994;59(6):665–678. doi:10.1006/exer.1994.1152.
  • Wilson SE. Corneal wound healing. Exp Eye Res. 2020;197:108089. doi:10.1016/j.exer.2020.108089.
  • Ljubimov AV, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res. 2015;49:17–45. doi:10.1016/j.preteyeres.2015.07.002.
  • Loureiro RR, Gomes JÁ. Biological modulation of corneal epithelial wound healing. Arq Bras Oftalmol. 2019;82(1):78–84. doi:10.5935/0004-2749.20190016.
  • Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol. 2009;9(7):491–502. doi:10.1038/nri2572.
  • Craxton A, Magaletti D, Ryan EJ, et al. Macrophage- and dendritic cell–dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood. 2003;101(11):4464–4471. doi:10.1182/blood-2002-10-3123.
  • Litinskiy MB, Nardelli B, Hilbert DM, et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and April. Nat Immunol. 2002;3(9):822–829. doi:10.1038/ni829.
  • Hardenberg G, Planelles L, Schwarte C, et al. Specific TLR ligands regulate April secretion by dendritic cells in a PKR-dependent manner. Eur J Immunol. 2007;37(10):2900–2911. doi:10.1002/eji.200737210.
  • Maślińska M, Przygodzka M, Kwiatkowska B, et al. Sjögren’s syndrome: still not fully understood disease. Rheumatol Int. 2015;35(2):233–241. doi:10.1007/s00296-014-3072-5.
  • Ryan MC, Grewal IS. Targeting of BAFF and April for autoimmunity and oncology. Adv Exp Med Biol. 2009;647:52–63.
  • Kapur R, Ebeling S, Hagenbeek A. B-cell involvement in chronic graft-versus-host disease. Haematologica. 2008;93(11):1702–1711. doi:10.3324/haematol.13311.
  • Shimabukuro-Vornhagen A, Hallek MJ, Storb RF, et al. The role of B cells in the pathogenesis of graft-versus-host disease. Blood. 2009;114(24):4919–4927. doi:10.1182/blood-2008-10-161638.
  • Kim JS, Kim S-J, Cheong J-W, et al. Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (April) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Korean J Hematol. 2011;46(3):175–179. doi:10.5045/kjh.2011.46.3.175.
  • Shen Z, Ma J, Peng R, et al. Biomarkers in ocular graft-versus-host disease: implications for the involvement of B cells. Transplant Cell Ther. 2022;28(11):749.e1–749.e7. doi:10.1016/j.jtct.2022.07.023.
  • Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8(3):221–233. doi:10.1038/nrm2125.
  • Fini ME, Girard MT, Matsubara M. Collagenolytic/gelatinolytic enzymes in corneal wound healing. Acta Ophthalmol. Suppl 1992;(202):26–33. doi:10.1111/j.1755-3768.1992.tb02165.x.
  • Fini ME, Cook JR, Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res. 1998;290:S12–S23. doi:10.1007/PL00007449.